CN Patent

CN104231067B — 促红细胞生成素模拟肽化学二聚体及其用途

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2017-08-11 · 9y expired

What this patent protects

本发明涉及促红细胞生成素模拟肽化学二聚体及其用途。特别地，本发明涉及式(I)所示的促红细胞生成素模拟肽化学二聚体，或其可药用盐，以及包含所述促红细胞生成素模拟肽化学二聚体或其可药用盐的组合物。本发明还涉及所述促红细胞生成素模拟肽化学二聚体或其可药用盐的用途。本发明的促红细胞生成素模拟肽化学二聚体或其可药用盐具有较好的促红细胞生成活性。

USPTO Abstract

本发明涉及促红细胞生成素模拟肽化学二聚体及其用途。特别地，本发明涉及式(I)所示的促红细胞生成素模拟肽化学二聚体，或其可药用盐，以及包含所述促红细胞生成素模拟肽化学二聚体或其可药用盐的组合物。本发明还涉及所述促红细胞生成素模拟肽化学二聚体或其可药用盐的用途。本发明的促红细胞生成素模拟肽化学二聚体或其可药用盐具有较好的促红细胞生成活性。

Drugs covered by this patent

Patent Metadata

Patent number
CN104231067B
Jurisdiction
CN
Classification
—
Expires
2017-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Pharmacology and Toxicology of AMMS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.